Considering the potential significance of VSOP/Hv1 as a therapeutic target for ischemic stroke or other neuropathology,12,14,15 it is important to fully understand the mechanisms by which VSOP/Hv1 affects ROS production. This evidence concerns the gene HVCN1 and ischemic stroke.